# Norstella: At Norstella, our mission is simple: to help patients gain access to life\-saving therapies\.

> Norstella is a group of market\-leading pharmaceutical solutions providers that help clients navigate complexities at each step of the drug development life cycle, from pipeline to patient\.

Generated by Yoast SEO v28.4, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Research \& Publications](https://www.norstella.com/research-publications/)
- [HLTH 2026](https://www.norstella.com/hlth-2026/)
- [Meet Norstella at ISPOR EU](https://www.norstella.com/meet-norstella-at-ispor-eu/)
- [The Market Access Landscape Is Moving\. Is Your Data Keeping Up?](https://www.norstella.com/the-market-access-landscape-is-moving/)
- [Enterprise Real\-World Data Infrastructure](https://www.norstella.com/enterprise-real-world-data-infrastructure/)

## Floating Elements
- [White Paper: Closing the Strategy Gap](https://www.norstella.com/e-floating-buttons/white-paper-closing-the-strategy-gap/)

## Employee Spotlights
- [Claire Riches](https://www.norstella.com/employee_spotlight/claire-riches/)
- [Allison Perry](https://www.norstella.com/employee_spotlight/allison-perry/)
- [Nicole Shalit](https://www.norstella.com/employee_spotlight/nicole-shalit/)
- [Tracey Barry](https://www.norstella.com/employee_spotlight/tracey-barry/)
- [Maxine Finding](https://www.norstella.com/employee_spotlight/maxine-finding/)

## Events
- [AMCP Nexus](https://www.norstella.com/events/amcp-nexus/): AMCP Nexus attracts more than 3,000 member and non\-member managed care decision\-makers\. Attendees include individuals from health plans, PBMs, biopharmaceutical companies, consultants, and other leaders working within managed care pharmacy\.  Enjoy education sessions, attend industry workshops, and experience the Expo where exhibitors will showcase the latest innovations and newest products\.

## Experts
- [Becky Hollenberg, MPH](https://www.norstella.com/experts/becky-hollenberg/)
- [Allison Perry, PhD](https://www.norstella.com/experts/allison-perry/)
- [Isabella Even\-Chen](https://www.norstella.com/experts/isabella-even-chen/)
- [Meghana Shamsunder, PhD, MPH](https://www.norstella.com/experts/meghana-shamsunder/)
- [Shrinal Patel](https://www.norstella.com/experts/shrinal-patel/)

## In the News
- [Roundup: Alteogen Enters Option \& License Agreement with Novartis\.\.\.](https://www.norstella.com/in-the-news/roundup-alteogen-enters-option-license-agreement-with-novartis-newbiologix-synastra-form-biotech-partnership-redhill-acquires-commercialization-rights-to-rebyota-clenpiq/)
- [Roundup: Shionogi Inc\. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Enters Global License Agreement with Genentech](https://www.norstella.com/in-the-news/roundup-shionogi-inc-acquires-intrabio-gate-bioscience-extends-collaboration-with-eli-lilly-alector-enters-global-license-agreement-with-genentech/)
- [Pharmaceutical companies push Trump administration to protect China deals](https://www.norstella.com/in-the-news/pharmaceutical-companies-push-trump-administration-to-protect-china-deals-2/)
- [Pharmaceutical Companies Push Trump Administration to Protect China Deals](https://www.norstella.com/in-the-news/pharmaceutical-companies-push-trump-administration-to-protect-china-deals/)
- [AstraZeneca Says Lung\-Disease Drug Shows Benefits Across Patient Groups](https://www.norstella.com/in-the-news/astrazeneca-says-lung-disease-drug-shows-benefits-across-patient-groups/)

## Insights
- [Connecting the Patient Story: From Fragmented Data to Meaningful Insight](https://www.norstella.com/insight/connecting-the-patient-story/): In healthcare analytics, what we know about patients depends on the data we can see\. That sounds obvious, but the implications are anything but\. 
- [Clinical Pathways: What Are They, and How Do They Affect Access?](https://www.norstella.com/insight/clinical-pathways-what-how-they-affect-access/)
- ["Built for Decisions, Not Demos": A Q\&A with Kris Kaneta on Norstella Atlas](https://ai.norstella.com/thought-leadership/built-decisions-not-demos-qa-kris-kaneta-atlas/)
- [Why an AI\-Native Biotech Chose Norstella](https://ai.norstella.com/thought-leadership/ai-native-biotech-norstella-citeline-recursion/)
- [Graph Intelligence: The Hidden Power of Clinical Trial Comparisons and Knowledge Discovery](https://ai.norstella.com/blog/clinical-trial-knowledge-graph-ai-similarity/)

## Research \& Publications
- [Healthcare Resource Utilization, Costs, and Characteristics of Treatment\-Naive and Switch Fabry Disease Patients Initiating Pegunigalsidase Alfa\-Iwxj in the US: A Retrospective Database Analysis](https://www.norstella.com/research-publication/healthcare-resource-utilization-costs-and-characteristics-of-treatment-naive-and-switch-fabry-disease-patients/)
- [Disease Burden and Severity Characterization of Atopic Dermatitis Using Real\-World Data from NorstellaLinQ: EMR and Open Claims with AI\-Extracted Clinical Insights](https://www.norstella.com/research-publication/disease-burden-and-severity-characterization-of-atopic-dermatitis-using-real-world-data-from-norstellalinq/)
- [Persistent Microhematuria and Risk of Long\-Term Kidney Failure in Adult Patients with Immunoglobulin A Nephropathy \(IgAN\) in the United States](https://www.norstella.com/research-publication/persistent-microhematuria-and-risk-of-long-term-kidney-failure-in-adult-patients-with-immunoglobulin-a-nephropathy-igan-in-the-united-states/)
- [Proteinuria and Risk of Kidney Failure in US Adults with Immunoglobulin A Nephropathy](https://www.norstella.com/research-publication/proteinuria-and-risk-of-kidney-failure-in-us-adults-with-immunoglobulin-a-nephropathy/)
- [Impact of Depression and Anxiety on Acute and Chronic Complications in Type 1 Diabetes: An EMR\-Based Matched Cohort Study](https://www.norstella.com/research-publication/impact-of-depression-and-anxiety-on-acute-and-chronic-complications-in-type-1-diabetes-an-emr-based-matched-cohort-study/)

## Press Releases
- [Norstella Launches Real\-World Data Agentic Platform and First Agent to Replace Manual Cohort Building](https://ai.norstella.com/press-release/launches-real-world-data-agentic-platform-first-agent-replace-manual-cohort-building/): New York – July 28, 2026: Norstella, the leading global provider of pharma intelligence solutions, today announced the launch of the Pipeline\-to\-Patient Productivity Index \(P3i\), a new annual benchmark measuring R\&D productivity, market access, and commercial return across the top 25 global biopharma companies\.
- [Norstella Launches Capsul, a Free Daily Intelligence Brief for the Pharma and Biotech Industry](https://www.norstella.com/press-releases/launches-capsul-free-daily-intelligence-brief-pharma-biotech-industry/): New York – July 28, 2026: Norstella, the leading global provider of pharma intelligence solutions, today announced the launch of the Pipeline\-to\-Patient Productivity Index \(P3i\), a new annual benchmark measuring R\&D productivity, market access, and commercial return across the top 25 global biopharma companies\.
- [MMIT \& The Dedham Group Unite to Smooth Access to Therapy](https://www.norstella.com/press-releases/press-release-mmit-the-dedham-group-unite-to-smooth-access-to-therapy/)
- [MMIT and Evaluate Join Forces to Offer an End\-to\-End View of the Pharmaceutical Market Landscape](https://www.norstella.com/press-releases/press-release-mmit-and-evaluate/)
- [MMIT/Evaluate Acquire Panalgo](https://www.norstella.com/press-releases/press-release-mmit-evaluate-acquire-panalgo/)

## Resources
- [How Citius Oncology Used Norstella’s RWD Solutions to Fuel Commercial Triggers and Focus Field Engagement](https://www.norstella.com/resource/how-citius-oncology-used-rwd-solutions/)
- [Introducing Trigger Alerts](https://www.norstella.com/resource/introducing-trigger-alerts/)
- [LinQ Notes: Get the “Why” Behind Treatment Decisions](https://www.norstella.com/resource/linq-notes-get-the-why-behind-treatment-decisions/)
- [LinQ Cohort: Accelerate Feasibility, Targeting, and Planning](https://www.norstella.com/resource/linq-cohort-accelerate-feasibility-targeting-planning/)
- [NorstellaLinQ Unstructured Data: Stop Searching\. Start Knowing\.](https://www.norstella.com/resource/norstellalinq-unstructured-data/)

## Categories
- [Case Study](https://www.norstella.com/category/resources/case-study/)
- [Infographic](https://www.norstella.com/category/resources/infographic/)
- [In the News](https://www.norstella.com/category/resources/in-the-news/)
- [Press Releases](https://www.norstella.com/category/resources/press-releases/)
- [Article](https://www.norstella.com/category/resources/article/)

## Tags
- [NorstellaLinQ](https://www.norstella.com/tag/norstellalinq/)
- [PharmaVoice](https://www.norstella.com/tag/pharmavoice/)
- [IHD](https://www.norstella.com/tag/ihd/)
- [The Wall Street Journal](https://www.norstella.com/tag/the-wall-street-journal/)
- [BioXconomy](https://www.norstella.com/tag/bioxconomy/)

## Publication Therapeutic Areas
- [Oncology](https://www.norstella.com/publication-therapeutic-areas/oncology/)
- [Cardiovascular](https://www.norstella.com/publication-therapeutic-areas/cardiovascular/)
- [CNS \& Neurology](https://www.norstella.com/publication-therapeutic-areas/cns-neurology/)
- [Endocrine \& Metabolic](https://www.norstella.com/publication-therapeutic-areas/endocrine-metabolic/)
- [Surgery](https://www.norstella.com/publication-therapeutic-areas/surgery/)

## Publication Topics
- [Cardiology](https://www.norstella.com/publication-topics/cardiology/)
- [Multiple Sclerosis](https://www.norstella.com/publication-topics/multiple-sclerosis/)
- [Diabetes](https://www.norstella.com/publication-topics/diabetes/)
- [Mental Health](https://www.norstella.com/publication-topics/mental-health/)
- [Breast Cancer](https://www.norstella.com/publication-topics/breast-cancer/)

## Publication Types
- [Conference Poster / Abstract](https://www.norstella.com/publication-types/conference-poster-abstract/)
- [Peer\-Reviewed Research](https://www.norstella.com/publication-types/peer-reviewed/)
- [Conference Presentation](https://www.norstella.com/publication-types/conference-presentation/)
- [Other](https://www.norstella.com/publication-types/other/)

## Publications Years
- [Before 2019](https://www.norstella.com/publications-year/before-2019/)
- [2024](https://www.norstella.com/publications-year/2024/)
- [2019](https://www.norstella.com/publications-year/2019/)
- [2020](https://www.norstella.com/publications-year/2020/)
- [2026](https://www.norstella.com/publications-year/2026/)

## Resource Topics
- [Real\-World Data](https://www.norstella.com/resource-topic/real-world-data/)
- [AI](https://www.norstella.com/resource-topic/ai/)
- [Market Trends](https://www.norstella.com/resource-topic/market-trends/)
- [Market Access](https://www.norstella.com/resource-topic/market-access/)
- [Clinical Trials](https://www.norstella.com/resource-topic/clinical-trials/)

## Optional
- [Sitemap index](https://www.norstella.com/sitemap_index.xml)